Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
N Engl J Med ; 348(22): 2196-203, 2003 May 29.
Article in English | MEDLINE | ID: mdl-12773646

ABSTRACT

BACKGROUND: In August 2002, fever and mental-status changes developed in recipients of organs from a common donor. Transmission of West Nile virus through organ transplantation was suspected. METHODS: We reviewed medical records, conducted interviews, and collected blood and tissue samples for testing with a variety of assays. Persons who donated blood to the organ donor and associated blood components were identified and tested for West Nile virus. RESULTS: We identified West Nile virus infection in the organ donor and in all four organ recipients. Encephalitis developed in three of the organ recipients, and febrile illness developed in one. Three recipients became seropositive for West Nile virus IgM antibody; the fourth recipient had brain tissue that was positive for West Nile virus by isolation and nucleic acid and antigen assays. Serum specimens obtained from the organ donor before and immediately after blood transfusions showed no evidence of West Nile virus; however, serum and plasma samples obtained at the time of organ recovery were positive on viral nucleic acid testing and viral culture. The organ donor had received blood transfusions from 63 donors. A review of blood donors and follow-up testing identified one donor who had viremia at the time of donation and who became seropositive for West Nile virus IgM antibodies during the next two months. CONCLUSIONS: Our investigation of this cluster documents the transmission of West Nile virus by organ transplantation. Organ recipients receiving immunosuppressive drugs may be at high risk for severe disease after West Nile virus infection. Blood transfusion was the probable source of the West Nile virus viremia in the organ donor.


Subject(s)
Blood-Borne Pathogens , Organ Transplantation/adverse effects , Transfusion Reaction , West Nile Fever/transmission , West Nile virus , Adult , Aged , Antibodies, Viral/blood , Blood Donors , Fatal Outcome , Female , Heart Transplantation/adverse effects , Humans , Immunoglobulin M/blood , Kidney Transplantation/adverse effects , Liver Transplantation/adverse effects , Male , Middle Aged , Tissue Donors , Viremia/diagnosis , Viremia/transmission , West Nile Fever/diagnosis , West Nile virus/immunology , West Nile virus/isolation & purification
2.
Chest ; 122(4): 1185-91, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12377840

ABSTRACT

STUDY OBJECTIVE: To demonstrate an association between saprophytic fungal infections occurring at the bronchial anastomosis (BA) and the development of additional complications arising at this site. DESIGN: Retrospective review. SETTING: University lung transplant center. MATERIALS AND METHODS: Review of all single-lung and double-lung transplant (LTX) recipients who underwent transplantation between June 1993 and December 2000. All recipients were subjected to surveillance bronchoscopy with biopsy at predetermined intervals and when clinically indicated. Bronchial wash fluid and biopsy material were examined using appropriate fungal stains and culture techniques. An infection was defined when fungal organisms were identified in tissue specimens. RESULTS: Fifteen saprophytic fungal infections involving the BA were identified in 61 LTX recipients (24.6%) who survived a minimum of 75 days post-transplantation. Infections were attributed to Aspergillus sp (n = 9), Candida sp (n = 2), Torulopsis sp (n = 1), and mixed flora (ie, Penicillium + Candida, two patients; and Aspergillus + Candida, one patient). Saprophytic fungal infections occurred by a median of postoperative day 35 (range, 13 to 159 days). Airway complications involving the BA ultimately developed in 11 of 61 recipients (18%). These complications included symptomatic bronchial stenosis (nine patients), bronchomalacia (one patient), and fatal hemorrhage (one patient). Bronchial complications arose in 7 of 15 recipients (46.7%) with saprophytic fungal infections of the BA in contrast to 4 of 46 (8.7%) without infections (p = 0.003, Fisher exact test). Also demonstrated was a positive correlation between anastomotic infections and bronchial complications (Phi coefficient = 0.43; p = 0.001), while logistic regression analysis revealed that the absence of anastomotic infections predicted the absence of such complications (p = 0.002). The risk of developing an additional complication following an anastomotic infection in patients with infections was five times that of those recipients without an infection (relative risk, 5.36; 95% confidence interval [CI], 1.82 to 15.79). The odds in favor of a bronchial complication following an infection were eight times greater than in those recipients without infection (odds ratio, 8.31; 95% CI, 1.96 to 35.16). CONCLUSIONS: Following LTX, saprophytic fungal infections of the BA are associated with serious airway complications.


Subject(s)
Aspergillosis/etiology , Bronchi/surgery , Candidiasis/etiology , Cryptococcosis/etiology , Lung Diseases, Fungal/etiology , Lung Transplantation/adverse effects , Adult , Age Distribution , Anastomosis, Surgical/adverse effects , Aspergillosis/epidemiology , Biopsy, Needle , Bronchi/microbiology , Bronchi/pathology , Bronchoscopy , Candidiasis/epidemiology , Cryptococcosis/epidemiology , Female , Humans , Incidence , Logistic Models , Lung Diseases, Fungal/microbiology , Lung Transplantation/methods , Male , Middle Aged , Odds Ratio , Probability , Prognosis , Retrospective Studies , Risk Assessment , Sex Distribution
3.
Int J STD AIDS ; 13(10): 724-6, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12396546

ABSTRACT

We report a case of paradoxical recurrent meningitis in response to initiation of highly active antiretroviral therapy in a patient receiving maintenance fluconazole for a previous diagnosis of cryptococcal meningitis. We describe the unusual radiographic and histopathologic findings which are consistent with an immune reconstitution induced paradoxical inflammatory response to residual cryptococcal infection.


Subject(s)
Acquired Immunodeficiency Syndrome/drug therapy , Acquired Immunodeficiency Syndrome/immunology , Antiretroviral Therapy, Highly Active/adverse effects , Meningitis, Cryptococcal/immunology , Adult , Antifungal Agents/therapeutic use , Fluconazole/therapeutic use , Humans , Male , Meningitis, Cryptococcal/drug therapy , Meningitis, Cryptococcal/pathology , Recurrence
SELECTION OF CITATIONS
SEARCH DETAIL
...